<p>Drug major Sun Pharmaceutical Industries on Tuesday reported a 12.92 per cent rise in its consolidated net profit to Rs 2,047.01 crore for the quarter ended on September 30, 2021.</p>.<p>The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.</p>.<p>Consolidated revenue from operations stood at Rs 9,625.93 crore for the quarter under consideration against Rs Rs 8,553.13 crore for the same period a year ago, it added.</p>.<p>Shares of Sun Pharmaceutical Industries were trading at Rs 816.05 per scrip on BSE, up 0.53 per cent from its previous close.</p>.<p><strong>Check out latest videos from <i data-stringify-type="italic">DH</i>:</strong></p>
<p>Drug major Sun Pharmaceutical Industries on Tuesday reported a 12.92 per cent rise in its consolidated net profit to Rs 2,047.01 crore for the quarter ended on September 30, 2021.</p>.<p>The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.</p>.<p>Consolidated revenue from operations stood at Rs 9,625.93 crore for the quarter under consideration against Rs Rs 8,553.13 crore for the same period a year ago, it added.</p>.<p>Shares of Sun Pharmaceutical Industries were trading at Rs 816.05 per scrip on BSE, up 0.53 per cent from its previous close.</p>.<p><strong>Check out latest videos from <i data-stringify-type="italic">DH</i>:</strong></p>